Loading...
Green Thumb Industries Inc.
GTII.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$7.19
CA$-0.07(-0.96%)
Green Thumb Industries Inc. (GTII.CN) Financial Performance & Statements
Review Green Thumb Industries Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
7.83%
↑ 7.83%
Operating Income Growth
21.55%
↑ 21.55%
Net Income Growth
101.51%
↑ 101.51%
Operating Cash Flow Growth
-13.24%
↓ 13.24%
Operating Margin
17.20%
↑ 17.20%
Gross Margin
52.54%
↑ 52.54%
Net Profit Margin
4.41%
↑ 4.41%
ROE
2.82%
↑ 2.82%
ROIC
8.24%
↑ 8.24%
Green Thumb Industries Inc. (GTII.CN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Green Thumb Industries Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $294.32M | $286.87M | $280.15M | $275.81M |
| Cost of Revenue | $136.25M | $139.27M | $129.63M | $130.88M |
| Gross Profit | $158.07M | $147.59M | $150.52M | $144.93M |
| Gross Profit Ratio | $0.54 | $0.51 | $0.54 | $0.53 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $100.96M | $104.97M | $96.50M | $74.26M |
| Operating Expenses | $100.96M | $104.97M | $96.50M | $74.26M |
| Total Costs & Expenses | $237.21M | $244.24M | $226.13M | $205.13M |
| Interest Income | $1.99M | $2.67M | $2.31M | $2.10M |
| Interest Expense | $5.47M | $5.30M | $5.98M | $7.51M |
| Depreciation & Amortization | $41.72M | $45.44M | $40.41M | $40.03M |
| EBITDA | $91.32M | $90.44M | $99.21M | $111.04M |
| EBITDA Ratio | $0.31 | $0.32 | $0.35 | $0.40 |
| Operating Income | $57.11M | $42.62M | $54.02M | $70.67M |
| Operating Income Ratio | $0.19 | $0.15 | $0.19 | $0.26 |
| Other Income/Expenses (Net) | -$12.99M | -$2.92M | -$1.20M | -$7.17M |
| Income Before Tax | $44.12M | $39.70M | $52.82M | $63.50M |
| Income Before Tax Ratio | $0.15 | $0.14 | $0.19 | $0.23 |
| Income Tax Expense | $31.32M | $30.92M | $31.90M | $32.15M |
| Net Income | $12.68M | $8.62M | $20.71M | $31.08M |
| Net Income Ratio | $0.04 | $0.03 | $0.07 | $0.11 |
| EPS | $0.07 | $0.05 | $0.09 | $0.13 |
| Diluted EPS | $0.07 | $0.05 | $0.09 | $0.13 |
| Weighted Avg Shares Outstanding | $236.85M | $236.30M | $237.42M | $236.76M |
| Weighted Avg Shares Outstanding (Diluted) | $239.06M | $238.30M | $240.14M | $240.56M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan